Documentos de Ceausu I. | REDI

Regresar

Mostrando 10 resultados de: 14

Filtros aplicados

Área temáticas: "Enfermedades"

Subtipo de publicación

Publisher

Área temáticas

Ginecología, obstetricia, pediatría, geriatría(11)

Salud y seguridad personal(4)

Farmacología y terapéutica(3)

Medicina y salud(2)

Economía laboral(1)

Área de conocimiento

Ginecología(8)

Salud mental(2)

Estudios de género(1)

Año de Publicación

Origen

Palabras Claves

Bisphosphonates(2)

Breast Cancer(2)

Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.

Palabras claves:

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement

Abstract: Introduction: Worldwide, there are 657 million women aged 45–59 and around half contribute to the la

Palabras claves:

aging, Employment, equality, gender, Guidelines, MENOPAUSE, workplace

Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Geukes M., Godfrey A., Goulis D.G., Griffiths A., Hardy C., Hickey M., Hirschberg A.L., Hunter M., Jack G., Kiesel L., Lambrinoudaki I., Lopes P., Mishra G.D., Oosterhof H., Peter A. Chedraui, Pines A., Rees M., Riach K., Shufelt C., van Trotsenburg M., Weiss R.

EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women

Abstract: Introduction Invasive as well as non-invasive methods are available for assessment of the endometriu

Palabras claves:

Clinical guide, Curettage, Endometrial assessment, Endometrial biopsy, Endometrial bleeding, Ultrasound

Antonsen S.L., Ceausu I., Depypere H., Dreisler E., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Poulsen L.G., Rees M., Simoncini T., Trémollieres F.A., Ulrich L.G.

EMAS clinical guide: Vulvar lichen sclerosus in peri and postmenopausal women

Abstract: Introduction: Vulvar lichen sclerosus (LS) is a chronic inflammatory disease which affects genital l

Palabras claves:

Calcineurin inhibitors, Clobetasol propionate, Corticosteroids, dyspareunia, Lichen sclerosus, Pimecrolimus, pruritus, Tacrolimus, Testosterone, Vulvar kraurosis

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Tamer Erel C., Trémollieres F.A., van der Schouw Y.T.

EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes

Abstract: Introduction Breast cancer is the most prevalent cancer in women, with slightly more than ten percen

Palabras claves:

Breast Cancer, Individualized, Mammography screening

Ceausu I., Depypere H., Desreux J., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.

EMAS position statement: Management of uterine fibroids

Abstract: Introduction Uterine fibroids (also termed leiomyomas or myomas) are the most common tumors of the f

Palabras claves:

Fibroids, Gn-RH analogs, High-intensity focused ultrasound, hysterectomy, Myomectomy, Ulipristal, Uterine artery embolization

Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Ornat L., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement

Abstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ost

Palabras claves:

Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acid

Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.

Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions

Palabras claves:

Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.

Osteoporosis management in patients with breast cancer: EMAS position statement

Abstract: Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog

Palabras claves:

adjuvant therapy, Aromatase inhibitors, Bisphosphonates, Breast Cancer, Denosumab, fractures, OSTEOPOROSIS, screening

Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A., van der Schouw Y.T.

Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement

Abstract: Introduction: Globally, the total number of people with depression exceeds 300 million, and the inci

Palabras claves:

Depression, Early menopause, EMAS, menopausal hormone therapy, Menopausal transition, Model of care, PERIMENOPAUSE

Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Karageorgiou V., Kiesel L., Lambrinoudaki I., Lindén Hirschberg A., Lopes P., Peter A. Chedraui, Pines A., Rees M., Spyropoulou A., Stute P., van Trotsenburg M., Zervas I.